Skip to main content
logo
Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.3900
+0.0600 (18.18%)
At close: Oct 16, 2026

Bio Essence Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
2.911.90.32-0.620.89
Revenue Growth
416.63%485.78%---30.00%-7.38%
Gross Profit
2.031.430.22-0.330.3
Operating Income
1.540.9-0.46-0.35-0.51-0.86
Net Income
1.520.9-1.31-0.97-0.81-0.65
Earnings Per Share
0.030.02-0.03-0.03-0.02-0.02
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
00000.010
Total Debt
1.571.562.713.294.623.96
Net Cash (Debt)
-1.57-1.56-2.71-3.29-4.61-3.96
Net Cash Growth
------
Net Cash Per Share
-0.04-0.04-0.07-0.10-0.14-0.12

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1.081.570.62-1.03-0.7-1.29
Capital Expenditures
----0-0-0.12
Free Cash Flow
1.081.570.62-1.03-0.71-1.41
Free Cash Flow Growth
16.68%151.62%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
69.68%75.28%67.01%-52.82%33.60%
Operating Margin
52.86%47.43%-141.83%--82.23%-96.57%
Pretax Margin
52.82%47.27%-483.09%--84.52%-72.55%
Profit Margin
52.12%47.23%-404.02%--130.26%-72.92%
FCF Margin
36.95%82.73%192.59%--113.74%-159.19%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
11.422.55----
P/FCF Ratio
19.511.4514.68---
PS Ratio
7.211.2028.28-29.21-